200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 14152-28-4
14152-28-4 | Prosta-10,13-dien-1-oic acid, 15-hydroxy-9-oxo-, (13E,15S)-
CAS No: 14152-28-4 Catalog No: AG001GJ2 MDL No:MFCD00077858
Product Description
Catalog Number:
AG001GJ2
Chemical Name:
Prosta-10,13-dien-1-oic acid, 15-hydroxy-9-oxo-, (13E,15S)-
CAS Number:
14152-28-4
Molecular Formula:
C20H32O4
Molecular Weight:
336.4657
MDL Number:
MFCD00077858
IUPAC Name:
7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic acid
InChI:
InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/b14-12+/t16-,17-,18+/m0/s1
InChI Key:
BGKHCLZFGPIKKU-LDDQNKHRSA-N
SMILES:
CCCCC[C@@H](/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O)O
UNII:
VYR271N44P
Properties
Complexity:
439
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
3
Defined Bond Stereocenter Count:
1
Exact Mass:
336.23g/mol
Formal Charge:
0
Heavy Atom Count:
24
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
336.472g/mol
Monoisotopic Mass:
336.23g/mol
Rotatable Bond Count:
13
Topological Polar Surface Area:
74.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.4
Literature
| Title | Journal |
|---|---|
| Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. | Bioorganic & medicinal chemistry 20121115 |
| A-class prostaglandins: early findings and new perspectives for overcoming tumor chemoresistance. | Cancer letters 20120728 |
| Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity. | Cancer research 20110615 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. | Journal of medicinal chemistry 20100722 |
| A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. | Chemico-biological interactions 20100105 |
| CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. | Journal of lipid research 20081001 |
| Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. | Journal of cell science 20080801 |
| Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. | Journal of microbiology and biotechnology 20080601 |
| Prostaglandins A1 and E1 influence gene expression in an established insect cell line (BCIRL-HzAM1 cells). | Insect biochemistry and molecular biology 20080301 |
| Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. | The EMBO journal 20071212 |
| Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin. | Journal of mass spectrometry : JMS 20071101 |
| Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. | Biochemistry 20070605 |
| Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. | Immunology and cell biology 20070101 |
| Addition of electrophilic lipids to actin alters filament structure. | Biochemical and biophysical research communications 20061103 |
| Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1. | Molecular pharmacology 20060901 |
| Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells. | European journal of pharmacology 20060807 |
| Prostaglandin A1 inhibits increases in intracellular calcium concentration, TXA(2) production and platelet activation. | Acta pharmacologica Sinica 20060501 |
| Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells. | The Journal of endocrinology 20060101 |
| Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. | FEBS letters 20051024 |
| Prostaglandin-induced neurodegeneration is associated with increased levels of oxidative markers and reduced by a mixture of antioxidants. | Journal of neuroscience research 20050701 |
| Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. | Biochemical and biophysical research communications 20040709 |
| Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK). | AIDS (London, England) 20040618 |
| Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells. | Journal of neuroscience research 20031001 |
| Absolute stereochemistry of allylic alcohols, amines, and other ene moieties: a microscale cross metathesis/exciton chirality protocol. | Journal of the American Chemical Society 20030910 |
| Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. | Cancer research 20030901 |
| Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate. | Molecular pharmacology 20030801 |
| Suppression of endothelial adhesion molecule up-regulation with cyclopentenone prostaglandins is dissociated from IkappaB-alpha kinase inhibition and cell death induction. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030601 |
| Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells. | Molecular carcinogenesis 20030501 |
| Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. | The Journal of biological chemistry 20030110 |
| Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. | Journal of neurochemistry 20021201 |
| Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20020701 |
| Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2. | Brain research 20020621 |
| A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. | Journal of immunology (Baltimore, Md. : 1950) 20020515 |
| Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. | The Journal of biological chemistry 20020510 |
| A chromatographic method for the quantification of prostaglandin E(1) and prostaglandin A(1) encapsulated in an intravenous lipid formulation. | Journal of pharmaceutical and biomedical analysis 20020415 |
| Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. | Prostaglandins, leukotrienes, and essential fatty acids 20011001 |
| Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. | The Journal of biological chemistry 20010803 |
| Regulation of prostaglandin A1-induced heat shock protein expression in isolated cardiomyocytes. | Journal of molecular and cellular cardiology 20010801 |
| Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect. | Virus research 20010501 |
| Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum. | The Journal of pharmacology and experimental therapeutics 20010401 |
| Effect of prostaglandin A1, arsenite and aspirin on stress proteins response in mosquito cells. | Zeitschrift fur Naturforschung. C, Journal of biosciences 20010101 |
| Inhibition of Mayaro virus replication by prostaglandin A(1) in Vero cells. | Intervirology 20010101 |
| Induction of the heat-shock response by antiviral prostaglandins in human cells infected with human immunodeficiency virus type 1. | European journal of biochemistry 19980901 |
| Prostaglandins stimulate the stress-induced synthesis of hsp27 and alpha B crystallin. | Journal of cellular physiology 19970301 |
| Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. | Proceedings of the National Academy of Sciences of the United States of America 19970121 |
| Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block. | The Journal of clinical investigation 19960415 |
| Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. | The Journal of general virology 19911101 |
| Screening for new compounds with antiherpes activity. | Antiviral research 19841001 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.